Filings
Finds words inside filing documents. Searching Tango Therapeutics, Inc.'s filings · 48 documents indexed.
16 documents · 25 matches
-
TNGX Tango Therapeutics, Inc. 10-K 2026-03-05
Item 1A. Risk Factors.
tariffs have led to increased trade and political tensions. In response to tariffs, other countries have implemented retaliatory tariffs on U.S. goods4 matches in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-10-23
tariffs, reciprocal and retaliatory tariffs, legal actions or enforcement and inflation or interest rates on Tango’s business, financial condition1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-06-08
tariffs, reciprocal and retaliatory tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-01-08
tariffs, reciprocal and retaliatory tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations1 match in this document -
TNGX Tango Therapeutics, Inc. 10-Q 2025-11-04
Item 1A. Risk Factors.
tariffs, sanctions, embargoes, export and import controls, and other trade restrictions, which can affect our operations, cause disruptions to our supply3 matches in this document -
TNGX Tango Therapeutics, Inc. 10-Q 2025-08-05
Item 1A. Risk Factors.
tariffs, sanctions, embargoes, export and import controls, and other trade restrictions, which can affect our operations, cause disruptions to our supply3 matches in this document -
TNGX Tango Therapeutics, Inc. 10-Q 2025-05-12
Item 1A. Risk Factors.
tariffs, sanctions, embargoes, export and import controls, and other trade restrictions, which can affect our operations, cause disruptions to our supply3 matches in this document -
TNGX Tango Therapeutics, Inc. 10-Q 2026-11-09
Item 6.
tariffs); regulatory requirements, legal actions, or enforcement; volatility in inflation or interest rates; and inadequate funding for government agencies on our business1 match in this document -
TNGX Tango Therapeutics, Inc. 10-Q 2026-08-11
Item 6.
tariffs); regulatory requirements, legal actions, or enforcement; volatility in inflation or interest rates; and inadequate funding for government agencies on our business1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-06-08
tariffs, legal actions or enforcement and inflation rates on Tango’s business, financial condition, and results of operations; inadequate funding1 match in this document -
TNGX Tango Therapeutics, Inc. 10-Q 2026-05-13
Item 6.
tariffs); regulatory requirements, legal actions, or enforcement; inflation rates; and inadequate funding for government agencies on our business, financial condition1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-03-05
tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations; inadequate funding for or disruptions1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-01-08
tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations; inadequate funding for or disruptions1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2026-01-05
tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations; inadequate funding for or disruptions1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2025-11-04
tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations; inadequate funding for or disruptions1 match in this document -
TNGX Tango Therapeutics, Inc. 8-K 2025-08-05
tariffs, legal actions or enforcement and inflation rates on our business, financial condition, and results of operations; inadequate funding for or disruptions1 match in this document
Page 1 of 1 · 16 documents